PRDX4 and plasma cell myeloma: At the same time, none of the tested phenotypes altered upon OTUD1 expression in myeloma cells (Ig production, proliferation, PI sensitivity) was affected by the absence of the KEAP1-binding site in OTUD1 (Supplementary Fig. 4b–d), prompting us to further investigate the role of PRDX4.